IMP-4-producing Pseudomonas aeruginosa in a French patient repatriated from Malaysia:: Impact of early detection and control measures

被引:10
作者
Bert, Frederic
Vanjak, Dominique
Leflon-Guibout, Veronique
Mrejen, Serge
Delpierre, Sandrine
Redondo, Aimee
Nicolas-Chanoine, Marie-Helene
机构
[1] Hop Beaujon, Microbiol Serv, Dept Microbiol, F-92110 Clichy, France
[2] Hop Beaujon, Dept Infect Control, F-92110 Clichy, France
[3] Hop Beaujon, Dept Neurosurg, F-92110 Clichy, France
[4] Hop Beaujon, Dept Gerontol, F-92110 Clichy, France
关键词
D O I
10.1086/511693
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:764 / 765
页数:2
相关论文
共 10 条
  • [1] IMP-4, a novel metallo-β-lactamase from nosocomial Acinetobacter spp. collected in Hong Kong between 1994 and 1998
    Chu, YW
    Afzal-Shah, M
    Houang, ETS
    Palepou, MFI
    Lyon, DJ
    Woodford, N
    Livermore, DM
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (03) : 710 - 714
  • [2] Occurrence of a new metallo-β-lactamase IMP-4 carried on a conjugative plasmid in Citrobacter youngae from the People's Republic of China
    Hawkey, PM
    Xiong, JH
    Ye, HF
    Li, HY
    M'Zali, FH
    [J]. FEMS MICROBIOLOGY LETTERS, 2001, 194 (01) : 53 - 57
  • [3] First detection of a carbapenem-hydrolyzing metalloenzyme in an Enterobacteriaceae isolate in France
    Lartigue, MF
    Poirel, L
    Nordmann, P
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (12) : 4929 - 4930
  • [4] Dissemination of the metallo-β-lactamase gene blaIMP-4 among gram-negative pathogens in a clinical setting in Australia
    Peleg, AY
    Franklin, C
    Bell, JM
    Spelman, DW
    [J]. CLINICAL INFECTIOUS DISEASES, 2005, 41 (11) : 1549 - 1556
  • [5] Emergence of IMP-4 metallo-β-lactamase in a clinical isolate from Australia
    Peleg, AY
    Franklin, C
    Bell, J
    Spelman, DW
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 54 (03) : 699 - 700
  • [6] Characterization of VIM-2, a carbapenem-hydrolyzing metallo-β-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France
    Poirel, L
    Naas, T
    Nicolas, D
    Collet, L
    Bellais, S
    Cavallo, JD
    Nordmann, P
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (04) : 891 - 897
  • [7] Acquired metallo-β-lactamases:: An increasing clinical threat
    Rossolini, GM
    [J]. CLINICAL INFECTIOUS DISEASES, 2005, 41 (11) : 1557 - 1558
  • [8] PCR typing of genetic determinants for metallo-β-lactamases and integrases carried by gram-negative bacteria isolated in Japan, with focus on the class 3 integron
    Shibata, N
    Yamane, YDK
    Yagi, T
    Kurokawa, H
    Shibayama, K
    Kato, H
    Kai, K
    Arakawa, Y
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (12) : 5407 - 5413
  • [9] Metallo-β-lactamases:: the quiet before the storm?
    Walsh, TR
    Toleman, MA
    Poirel, L
    Nordmann, P
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 2005, 18 (02) : 306 - +
  • [10] Imipenem-EDTA disk method for differentiation of metallo-β-lactamase-producing clinical isolates of Pseudomonas spp. and Acinetobacter spp.
    Yong, DE
    Lee, K
    Yum, JH
    Shin, HB
    Rossolini, GM
    Chong, YS
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (10) : 3798 - 3801